Navigation Links
Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
Date:5/15/2013

listed on a national exchange; that we can raise sufficient capital from partnering, monetization or other fundraising transactions to maintain our stock exchange listing or adequately fund ongoing operations; that the Company can attract suitable commercialization partners for our products or that we or partners can successfully commercialize them; that our product or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive or blocked by third party proprietary rights or other means; that the products and product candidates referred to in this report or in our other reports will be successfully commercialized and their use reimbursed, or will enhance our market value; that our To Go Brands business can be successfully integrated and expanded; that new product opportunities or commercialization efforts will be successfully established; that third parties on whom we depend will perform as anticipated; that the preferred stock offering can be completed as proposed or that the Company will not be adversely affected by risks and uncertainties that could impact our operations, business or other matters, as described in more detail in our filings with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2013 Cardium Therapeutics, Inc.  All rights reserved.
For Terms of Use Privacy Policy, please visit www.cardiumthx.com.

Cardium Therapeutics®, Generx®, Cardionovo®, Tissue Repair™, Excellagen®, Excellarate™, LifeAgain™, Genedexa™, Neo-Apps®, Me
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cardium Announces Generx Publication In Molecular Therapy
2. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
3. Cardium Presents Year-End 2012 Financial Results And Recent Developments
4. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
5. Cardium Receives ISO Certification for Excellagen
6. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
7. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
8. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
9. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
10. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
11. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... YORK , Sept. 3, 2015 This ... used to save millions of lives across globe. This ... Kingdom of Saudi Arabia . Stakeholders ... material suppliers, government agencies and regulatory bodies. The ... studied from two perspectives: by products and by end ...
(Date:9/3/2015)... Calif. , Sept. 3, 2015 Nevro ... company that is providing innovative evidence-based solutions for the ... will be presenting at the Morgan Stanley Global Healthcare ... City.  Nevro management is scheduled to ... accessible via a live audio webcast, accessible in the ...
(Date:9/3/2015)... 2015  Ascendis Pharma A/S (Nasdaq: ... that applies its innovative TransCon technology to ... plans to present at several upcoming investor ... in BostonDate: , Thursday, September 10, 2015 Time: ... Merrill Lynch Global Healthcare Conference in LondonDate: ...
Breaking Medicine Technology:Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
... LOS ANGELES , July 13 Medical Tactile, Inc. ... Medical Technologies, Inc., based in Victoria , Canada , has ... the exclusive Sales & Marketing rights for SureTouch™ , the non-invasive ... , , , ...
... New England Biolabs (NEB) has expanded its line ... Quick DNA Sample Prep Reagent Set 2 and Master Mix ... GS FLX Titanium™ and GS Junior™ instruments. These new products ... library preparation. The Master Mix Set further streamlines the workflow, ...
Cached Medicine Technology:Partnership Brings Breast Image Documentation Technology to Women Around the World 2New England Biolabs Launches NEBNext™ Quick DNA Sample Prep Reagent Sets for Use With Roche/454 Next Generation Sequencing Platforms 2
(Date:9/4/2015)... Forge, PA (PRWEB) , ... September 04, 2015 , ... ... growth in and around the home is quite common. Mold can grow anywhere - ... areas around leaking pipes. Checking for excessive moisture and water in the home is ...
(Date:9/4/2015)... ... ... are looking for a quick and convenient way to produce a hot remedy for colds. ... a quick and simple way to brew a hot cup of cold remedy when desired. ... they enhance comfort and health. The invention features a novel design that is lightweight, compact ...
(Date:9/4/2015)... ... ... Having access to a doctor can sometimes be a challenge for a variety ... visits which affects hospitals’ abilities to provide quality service to those with serious needs, ... this problem has recently presented itself, the new telemedicine platform and app, DocChat ...
(Date:9/4/2015)... DC (PRWEB) , ... September 04, 2015 , ... ... they all pale in comparison to settlements under the Stark physician self-referral law. ... an upcoming Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will detail ...
(Date:9/4/2015)... ... 04, 2015 , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg ... Hope event supporting families affected by autism, raising nearly $250,000. , 150 guests, ... at the Oscar Swan Inn to support the cause. , McCarthy tugged the ...
Breaking Medicine News(10 mins):Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... , SUNDAY, June 5 (HealthDay News) -- Four of the ... serious birth defects when taken early in pregnancy, a new study ... risk, the international team of researchers reported in the June 6 ... show that dose selection is as crucial as the choice of ...
... By Amanda Gardner HealthDay Reporter , SUNDAY, June ... cancer only take four courses of two chemotherapy drugs and ... those drugs may delay return of the deadly disease, new ... Spanish scientists report that staying on Alimta (pemextrexed) delayed recurrence ...
... Amanda Gardner HealthDay Reporter , SATURDAY, June ... to cut the odds of breast cancer by 65 ... And unlike other anti-estrogen therapies such as tamoxifen ... risk of endocrine cancer or blood clots, although it ...
... YORK (June 5, 2011) Less invasive catheter-based aortic valve ... for patients at high risk for surgery. Results from ... world,s first randomized clinical trial of a transcatheter aortic heart ... Journal of Medicine . The findings were also presented on ...
... Reporter , SATURDAY, June 4 (HealthDay News) -- For ... suggests that the sooner chemotherapy starts following the operation, ... the first four weeks post-surgery that chemotherapy is delayed, ... "What our research has indicated is that giving ...
... individuals with Lynch syndrome, a hereditary cancer syndrome that carries ... of other cancers, researchers have identified mutations associated with a ... for ovarian and endometrial cancer, according to a study in ... issue on cancer. The study is being published early online ...
Cached Medicine News:Health News:Epilepsy Drugs' Risk of Birth Defects May Be Dose-Dependent 2Health News:Epilepsy Drugs' Risk of Birth Defects May Be Dose-Dependent 3Health News:Taking Chemo Drug Continuously Delayed Lung Cancer's Return 2Health News:Taking Chemo Drug Continuously Delayed Lung Cancer's Return 3Health News:Aromasin Reduced Breast Cancer Risk in Postmenopausal Women 2Health News:Aromasin Reduced Breast Cancer Risk in Postmenopausal Women 3Health News:PARTNER shows similar 1-year survival for catheter-based AVR and open AVR in high-risk patients 2Health News:PARTNER shows similar 1-year survival for catheter-based AVR and open AVR in high-risk patients 3Health News:After Colon Cancer Surgery, Early Chemo May Pay Off 2Health News:After Colon Cancer Surgery, Early Chemo May Pay Off 3Health News:Study identifies genetic mutations associated with cancer risk for hereditary cancer syndrome 2Health News:Study identifies genetic mutations associated with cancer risk for hereditary cancer syndrome 3
The ultra micro tip for the new Eppendorf 2000/2100 series ultra micro pipettors provides accurate drawing and dispensing everytime....
... Sterilized Diamond Tips are available as ... Tips are irradiated by gamma-rays for more ... certificate of sterilization, specifying the date of ... usepractical, no need to autoclave. SterilPack Diamond ...
This ultra micro tip for the Eppendorf and Nichiryo/BenchMate 0.5-10 L pipettors is perfect for working with low volume....
1000 L, Bulk Recommended for 500 and 1000 L pipettes....
Medicine Products: